20 January 2012
2012 is getting off to a fast start. Those of you who were at JP Morgan in San Francisco last week will have noticed the increased pace of pharma to biotech and pharma to VC meetings taking place. Major deals have been signed and more are in the works, so while we are by no means at the end of the tunnel for biotechnology transfer and venture, it does seem like 2012 will be a more active year than 2011.
But what about technology transfer in biotech and healthcare? The good news is, the Global Tech Transfer Initiative is stronger than ever, and we look forward to seeing you at key Summits in Europe (25-26 June at the Pasteur Institute), North America, and Australia. We will announce the full dates and venues soon, but in the meantime, there are a number of important affiliate events supported or endorsed by TTS.
Perhaps most important of these is the European Commission’s “Innovation in Healthcare: Across Borders” conference on 16-17 April in Brussels. This is the EC’s key policy event related to healthcare innovation, and technology transfer takes a central role, so we encourage all members of the TTS network to be there. Registration is free, so join us in taking part and making sure technology transfer, access to finance for biotech start-ups, and other key issues in healthcare innovation receive the attention they need, and benefit from real stakeholder input. TTS Ltd is proud to once again be contributing to the programme of the Innovation in Healthcare meeting.
There are also a number of key international events in emerging biotech markets. In February, we are participating in BioAsia 2012 in Hyderabad, one of the key meetings for the biotech sector in India.
The BioVision Alexandria meeting on 22-25 April in Alexandria, Egypt, takes place every 2 years and remains the key international biotech meeting for the developing world. Those interested to support biotech innovation in developing and emerging markets are encouraged to visit the Library of Alexandria and get involved in this key initiative, likely to be even more ambitious following the changes in the Middle East over the past year.
And finally BioInvest Israel on 5-6 March in Haifa will provide unique partnering access to key biotech and medical device innovators and stakeholders in Israel. Watch for announcements for a 10% registration discount.
In Europe, BioVaria 2012 provides an excellent technology pitching platform on 15 May in Muncih, and on May 30 - June 1 in Berlin, the ASTP annual conference brings together the members of the Association of Technology Professionals for their annual meeting and discussion of TTO issues and training.
The Global Tech Transfer Initiative supports key international events, which help to build a global community and network of the key leaders in biotechnology and related technology transfer, innovation and venture, and to provide all of you with access to this key community. We look forward to seeing you at one or more of these key international meetings, as well as major conferences like BIO, and of course at the Tech Transfer Summits themselves, where the leading tech transfer and innovation stakeholders join together for two days of high level, interactive expert round-table discussions, debate, best practices and networking.
December 7, 2013